文献速递前列腺癌

比较前列腺活检前是否行多参数磁共振成像对前列腺癌检出影响:观察性队列研究

Comparison of Prostate Biopsy with or without Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Detection: An Observational Cohort Study.
PubMed 文献 · J Urol · 2019-01-01

该观察性队列研究纳入997例直接行经直肠前列腺活检的患者(队列1)和792例活检前行多参数磁共振成像(mpMRI)的患者(队列2)。结果显示,引入活检前mpMRI未增加总体前列腺癌检出率(57.6% vs 56.7%,p=0.701),但若mpMRI阴性时省略系统活检,将漏诊15.1%的Gleason分级分组≥2的前列腺癌。

要点

  • 活检前mpMRI未提高总体前列腺癌检出率(57.6% vs 56.7%,p=0.701)。
  • mpMRI阴性时省略系统活检会漏诊15.1%的Gleason分级分组≥2前列腺癌。
  • mpMRI对Gleason分级分组2-5前列腺癌的阴性预测值为84%。

核心结论

  • 引入活检前mpMRI增加了每个活检核心的前列腺癌诊断率,但未增加总体前列腺癌检出率;mpMRI阴性时省略系统活检将导致15.1%的Gleason分级分组≥2前列腺癌漏诊。

研究设计与样本

  • 观察性队列研究,997例活检初治患者仅行经直肠前列腺活检(队列1,至2016年6月),此后792例患者行活检前mpMRI后经直肠前列腺活检(队列2)。

主要发现

  • 队列2与队列1相比,总体前列腺癌检出率无增加(57.6% vs 56.7%,p=0.701),Gleason分级分组或阳性针数无差异(各p>0.05)。
  • 队列2中多灶性前列腺上皮内瘤变、最大前列腺癌针长(≥5 mm vs <5 mm)及根治性手术/高强度聚焦超声的比例增加(各p<0.05)。
  • 对于Gleason分级分组2-5前列腺癌,活检前mpMRI阴性的敏感性为88.1%,特异性为59.8%,阳性预测值为67.8%,阴性预测值为84%。
  • 对于活检前mpMRI阴性者,前列腺特异性抗原密度 cutoff ≥0.15 ng/ml² 仅在临床显著前列腺癌定义为Gleason分级分组3-5和/或肿瘤长度≥6 mm时提高检出。

关键数值与推荐

  • 活检前mpMRI阴性时省略系统经直肠前列腺活检将漏诊15.1%的Gleason分级分组≥2前列腺癌(约1/6)。
  • Gleason分级分组2-5前列腺癌的mpMRI阴性预测值为84%。

临床怎么用

  • 活检前mpMRI可用于靶向活检,但mpMRI阴性时不应省略系统活检以避免漏诊临床显著前列腺癌。
  • 对于mpMRI阴性患者,可考虑结合前列腺特异性抗原密度(cutoff ≥0.15 ng/ml²)决定是否活检,但需注意其仅对特定定义的临床显著癌提高检出。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We hypothesized that 1) introducing prebiopsy multiparametric magnetic resonance imaging would increase the diagnostic yield of transrectal prostate biopsy and 2) this would inform recommendations regarding systematic transrectal prostate biopsy in the setting of negative prebiopsy multiparametric magnetic resonance imaging. MATERIALS AND METHODS: A total of 997 biopsy naïve patients underwent transrectal prostate biopsy alone to June 2016 (cohort 1) and thereafter 792 underwent transrectal prostate biopsy following prebiopsy multiparametric magnetic resonance imaging (cohort 2). Patients with lesions on prebiopsy multiparametric magnetic resonance imaging underwent cognitive targeted plus systematic transrectal prostate biopsy. Patients without lesions underwent systematic transrectal prostate biopsy. RESULTS: Cohort 2 comprised younger men (age 68 vs 69 years, p = 0.01) with lower prostate specific antigen (7.6 vs 7.9 ng/ml, p = 0.024) and smaller prostate volume (56.1 vs 62 cc, p = 0.006). In cohort 2 vs cohort 1 there was no increase in overall prostate cancer detection (57.6% vs 56.7%, p = 0.701), the Gleason Grade Group or the number of positive cores (each p >0.05). Increased multifocal prostatic intraepithelial neoplasia, maximum prostate cancer core length (5 mm or greater vs less than 5 mm) and radical surgery/high intensity focused ultrasound (each p <0.05) were observed in cohort 2. For Gleason Grade Group 2-5 prostate cancer negative prebiopsy multiparametric magnetic resonance imaging had 88.1% sensitivity, 59.8% specificity, 67.8% positive predictive value and 84% negative predictive value. For negative prebiopsy multiparametric magnetic resonance images a prostate specific antigen density cutoff of 0.15 ng/ml2 or greater increased clinically significant prostate cancer detection only if the latter was defined as Gleason Grade Group 3-5 disease and/or tumor length 6 mm or greater. CONCLUSIONS: Introducing prebiopsy multiparametric magnetic resonance imaging in our clinical setting increased the diagnostic yield of prostate cancer per biopsy core. Not performing a systematic transrectal prostate biopsy when prebiopsy multiparametric magnetic resonance imaging was negative would have led to under detection of 15.1% of Gleason Grade Group 2 or greater prostate cancer cases (approximately 1 in 6).

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Bryant RJ, Hobbs CP, Eyre KS, et al. Comparison of Prostate Biopsy with or without Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Detection: An Observational Cohort Study. J Urol. 2019. PMID: 30266332. doi:10.1016/j.juro.2018.09.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。